Search Results
Oct 03, 2025, 02:00 ET Il Dipartimento di Medicina Clinica e Molecolare di Sapienza Università di Roma, Takis e Tethis iniziano una collaborazione per promuovere lo sviluppo di terapie e diagnostica mirate contro HER3
tecnologie innovative, tra cui il trasferimento di DNA. Takis sta attivamente sviluppando anticorpi monoclonali e molecole bispecifiche per l'oncologia e le malattie infettive, compreso il COVID-19. L'azienda ha inoltre sviluppato COVID-eVax, un vaccino a DNA contro il SARS-CoV-2, e continua ad applicare
More news about: Tethis S.p.A.
Oct 02, 2025, 20:42 ET Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT
community settings." To achieve dual detection, the Nutromics team deployed a wearable patch with microneedles coated in synthetic DNA-based sensors (or aptamers), one specific to vancomycin, the other tobramycin. Each aptamer responded selectively to its target drug without interference
More news about: Nutromics
Oct 02, 2025, 18:37 ET FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Zepzelca is an alkylating drug that binds guanine residues within DNA. This triggers a cascade of events that can affect the activity of DNA binding proteins, including some transcription factors, and DNA repair pathways, resulting in disruption of the cell cycle and potentially cell death.1
More news about: Jazz Pharmaceuticals plc
Oct 02, 2025, 09:00 ET Chili's® Sets the Queso Standard with All-New Southwestern Queso
the perfect pairing for Chili's iconic tortilla chips. Listening to guests and restaurant teams for real-time feedback is a crucial piece of Chili's DNA and a critical part of this process. In a taste test, nearly 70% of respondents prefer the new, refined flavor profile of the Southwestern Queso when
More news about: Chili's Grill & Bar
Oct 02, 2025, 08:05 ET INOVIO Reports Inducement Grant Under Inducement Plan
company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its
More news about: INOVIO Pharmaceuticals, Inc.
Oct 02, 2025, 08:00 ET CELLS and FITCI Partner to Launch a Community Biotechnology Lab
Educational Workshops: Hands-on classes for students and curious adults to explore topics like DNA extraction, microbiology, and genetic engineering. Open Lab Access: A collaborative environment where citizen scientists and
More news about: Frederick Innovative Technology Center, Inc.
Oct 02, 2025, 07:50 ET AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
integrates the wisdom of traditional medicine with state-of-the-art technologies. Patented Flagship NB-A002 is a First-in-class DNA Damage Response ("DDR") therapeutic product candidate, targeting the previously undruggable target ILF2, inducing synthetic lethality in DDR and Homologous
More news about: NYB Holdings Limited
Oct 02, 2025, 07:00 ET The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
across its drug-candidate pipeline and proprietary nutraceuticals. NYB is developing first-in-class precision medicines for cancers caused by DNA damage repair (DDR) deficiencies and drug resistance. NYB's lead candidate, NB-A002, has achieved successful preclinical results. NB-A002 is the first
More news about: The9 Limited
Oct 01, 2025, 19:23 ET Pacific Northwest Research Institute Publishes Key Advances in Rare and Genetic Disease Research Amid National Funding Uncertainty
Genomic rearrangements: Dr. Cláudia Carvalho's lab mapped repeated DNA sequences and chromosomal inversions that can trigger structural changes in the human genome. Their work revealed how hidden rearrangements disrupt disease
More news about: Pacific Northwest Research Institute
Oct 01, 2025, 09:18 ET 13-YEAR-OLD GEN ZALPHA FOUNDER COCO GRANDERSON TEAMS UP WITH SKINCARE ICON RON ROBINSON TO LAUNCH YES DAY™, THE FIRST GLOW-INDUCING LINE FOR TEENS AND TWEENS
proprietary Yes Magic™ complex of probiotics, moisture-binding magnets, and antioxidants, the collection is safe for teens and in-betweens. With a brand DNA that is teen-worthy, trustworthy, crave-worthy, and planet-worthy, Yes Day™ is more than skincare — it's a happy place for teens to build healthy routines,
More news about: YES DAY
Oct 01, 2025, 09:05 ET SafeTraces Selected as a Prime Performer for ARPA-H Building Resilient Environments for Air and Total Health (BREATHE) Program on Other Transaction Agreement up to $39 Million
prevent airborne biological threats. Developed with National Institutes of Health support, the company's veriDART® platform, which leverages DNA-tagged tracer particles to simulate emission, mobility, and exposure to airborne pathogens, has been employed by Amazon, Google, Mayo Clinic, State of
More news about: SafeTraces, Inc.
Oct 01, 2025, 09:05 ET Illumina launches new business to accelerate technology and data-driven discovery
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Oct 01, 2025, 08:30 ET Nuveen Introduces Global Multi-Asset Infrastructure Platform to Accelerate Growth of $340 Billion Private Markets Business
of each team remain unchanged. The Infrastructure Platform will benefit from the deep bench of infrastructure investment expertise core to the firm's DNA as one of the largest municipal bond managers, with $190 billion in AUM.4 Core Investment Capabilities
More news about: Nuveen
Oct 01, 2025, 07:00 ET VisionSys AI Launches an up to $2 Billion Solana Treasury Initiative in Exclusive Partnership with Marinade Finance
community-driven governance. "This Partnership represents a once-in-a-generation opportunity to integrate digital assets into our corporate DNA," said Heng Wang, Chief Executive Officer of VisionSys AI Inc. "It positions VisionSys as a pioneer of AI-driven blockchain treasury management. By leveraging
More news about: VisionSys AI Inc.
Oct 01, 2025, 06:41 ET Comemoração do 50º aniversário da Linglong Tire começa em Londres
"fabricação inteligente", a Linglong continuará aumentando o investimento em P&D e inovação, incorporando segurança, sustentabilidade e inteligência ao DNA de seus produtos. De "local" ao "global", a empresa aprofundará suas operações internacionais, mostrando a força das marcas chinesas no cenário mundial!
More news about: Shandong Linglong Tyre Co., Ltd.
Sep 30, 2025, 17:31 ET HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight
carcinoma (OPSCC). Inovio Pharmaceuticals/MedImmune's INO-3112 is a DNA-based therapeutic candidate that targets HPV 16/18 and incorporates a DNA plasmid encoding IL-12 to enhance immune activation. INOVIO is assessing its ability to generate antigen-specific
More news about: DelveInsight Business Research, LLP
Sep 30, 2025, 14:41 ET Die Feier zum 50-jährigen Bestehen von Linglong Tire beginnt in London
Fertigung" wird Linglong weiterhin verstärkt in Forschung und Entwicklung sowie Innovation investieren und Sicherheit, Nachhaltigkeit und Intelligenz in die DNA seiner Produkte integrieren. Von „lokal" bis „global" wird das Unternehmen seine internationalen Aktivitäten ausbauen und die Stärke chinesischer Marken
More news about: Shandong Linglong Tyre Co., Ltd.
Sep 30, 2025, 14:30 ET AlphaPoint Appoints Joaquín Ayuso de Paúl as Chief Product Officer and Lauren Nichols as Vice President of Sales
applications with secure, scalable digital-asset infrastructure," said Igor Telyatnikov, CEO of AlphaPoint. "Joaquín brings a rare combination of founder DNA and product leadership across payments, banking, and crypto infrastructure, while Lauren has built and led high-performing go-to-market
More news about: AlphaPoint Corporation
Sep 30, 2025, 09:30 ET Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Sep 30, 2025, 09:11 ET Navinci Launches Naveni® Plex Omni Service Providing Expert-Led Access to Spatial Interactomics
differently to immunotherapy. Navinci's proprietary misPLA technology uses antibody-oligonucleotide pairs that form amplifiable DNA upon proximal binding, enabling rolling circle amplification and precise detection of protein interactions and modifications, even for rare or transient
More news about: Navinci
Sep 30, 2025, 09:07 ET Navinci Launches Naveni® Plex Omni Service Providing Expert-Led Access to Spatial Interactomics
differently to immunotherapy. Navinci's proprietary misPLA technology uses antibody-oligonucleotide pairs that form amplifiable DNA upon proximal binding, enabling rolling circle amplification and precise detection of protein interactions and modifications, even for rare or transient
More news about: Navinci
Sep 30, 2025, 09:00 ET K18 and Future Society Launch First-Ever Biotech Beauty Collaboration With Limited-Edition Floating Forest Hair Mask
brings together K18's category-defining hair repair technology with Future Society's groundbreaking approach to fragrance, made from extinct flower DNA, marking a milestone for biotech beauty uniting two categories through shared science and imagination. "At
More news about: K18 Biomimetic Hairscience
Sep 30, 2025, 09:00 ET SurfYogaBeer Turns Nicaragua Into the World's Hottest Destination for Solo Travelers
the Turkish Riviera to skiing the French Alps, trail running in Ireland, and biking Italian lake towns. While surf, yoga and beer remain part of its DNA, SYB has evolved into the platform for travelers seeking movement, connection, and unforgettable experiences with a crew. "We
More news about: SurfYogaBeer
Sep 30, 2025, 09:00 ET MetTel and TekSynap Announce Strategic Partnership to Deliver Agile, Secure Communications Solutions for U.S. Defense and Intelligence Agencies
resilience across mission-critical operations, even for the most challenging environments With a shared DNA rooted in adaptability, mission focus, and technical excellence, MetTel and TekSynap are poised to usher in a new era of what agile, innovative companies
More news about: MetTel
Sep 30, 2025, 08:34 ET Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features
hPTMs and DNA methylation from minimal sample volumes. The reduced cost per sample is a key advantage, making large-scale studies more accessible than ever. EpiFinder™ GenomePro has a flexible design, allowing researchers to choose their desired hPTMs with or without DNA methylation.
More news about: Epigenica AB